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An Investigation into Clozapine Prescribing Among Psychiatrists in Australia 
 
Background: Clozapine is an effective antipsychotic for the management of treatment-
resistant schizophrenia. There is a lack of knowledge of the clozapine prescribing patterns of 
psychiatrists in Australia. 
 
Objective: The aims of the study were to identify prescribing patterns for clozapine in 
Australia; identify at what time point and under what circumstances clozapine treatment is 
initiated in Australia; assess the views of psychiatrists to clozapine treatment; understand 
reasons why some psychiatrists are reluctant to prescribe clozapine; and identify treatment 
strategies for patients with schizophrenia who do not or partially respond to clozapine. 
 
Method: A cross-sectional survey was developed using online survey software, and 
psychiatrists were invited to participate through a monthly edition of the Royal Australian 
and New Zealand College of Psychiatrists e-Psych online newsletter. 
 
Results: Sixty-two psychiatrists completed the survey, with over 40% of respondents 
between the ages of 35-44 years, and working in one or a combination of the public, private 
and tertiary settings. From the survey population, 69% of respondents stated they would 
commence a patient on clozapine treatment after two unsuccessful trials of other 
antipsychotics. Twenty-three percent of respondents were reluctant to prescribe clozapine to 
their patients, and 2 in 5 psychiatrists with greater than ten years' experience, reported a 
reluctance to prescribe. Leading the reasons for reluctance was the concern that individuals 
may develop metabolic syndrome, and chronic physical health issues that are associated with 
weight gain. 
 
Conclusions: The survey responses suggest a need for further investigation into the reasons 
for disparity between clozapine knowledge and understanding, and the reluctance to 
prescribe. 
